相关实验视频
Updated: Jun 5, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.4K
实施多药店管理框架的障碍和促进因素:对关键利益相关者的基于理论的定性探索
S Al Bulushi1,2, T McIntosh2, H Talkhan3
1Ministry of Health, Muscat, Oman.
International journal of clinical pharmacy
|December 12, 2024
概括
实施组织的多药房管理框架面临障碍和促进者. 关键因素包括利益相关者的意识,电子健康系统和政策的缺失,特别是在医疗保健组织的内部环境中.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 实施科学 实施科学
- 药物管理 药物管理
背景情况:
- 不适当的多药是个重大问题,往往源于处方过程的缺陷.
- 现有的研究主要针对临床医生/患者层面的干预措施,忽视了组织层面的解决方案.
研究的目的:
- 确定实施组织级多药店管理框架的障碍和促进因素.
- 探讨阿曼卫生部内主要利益相关者的观点.
主要方法:
- 使用半结构面试进行的定性研究,对13个有意抽样的关键利益相关者进行了采访.
- 采访由实施研究综合框架 (CFIR) 提供信息,并使用框架方法进行分析.
- 数据收集一直持续到和,采访被录音,转录和分析.
主要成果:
- 促进者包括利益相关者意识,电子卫生系统,国家领导力,证据差距,个人冠军和变革战略.
- 在内部设置 (政策缺失,沟通问题,专业实践) 和外部设置 (资源需求) 中确定了障碍.
- 大多数障碍都集中在组织内部.
结论:
- 该研究确定了实施组织多药店管理框架的关键促进者和障碍.
- 将这些发现转化为可行的计划是成功实施框架的必要条件.
- 医疗保健组织的内部环境需要集中注意力,因为已识别的障碍物集中在其中.
更多相关视频
相关概念视频
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
Barriers to Effective Communication II
3.6K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.6K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56
Drug Control Governance: Regulatory Bodies and Their Impact
141
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
141
Analysis of Population Pharmacokinetic Data
232
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
232

